Remove 2017 Remove Drug Development Remove Health Information
article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. You may now kiss the cancer survivor. Just like any marriage is more than its license, patients are wondering how the FDA PFDD guidelines will be enforced.

BioTech 112
article thumbnail

Asaya and medical cannabis care in the era of personalised medicine

Lloyd Price

Desperate for medical insights without delay, researchers, pharmaceutical companies and government agencies turned to health information captured through real-world data sources. A new medication is introduced to the market via legislation rather than through formal drug development practices (3); 3. 6 May 2017.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Blockchain in Healthcare: A Vehicle Towards Digital Health 2.0?

The Digital Health Corner

Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health. According to an excellent whitepaper describing a case study of Medrec , a platform utilizing blockchain technology, health information interoperability is facilitated with the use of blockchain.

article thumbnail

Sex, Gender, and the Brain: The Women’s Brain Foundation and Medscape Education Announce Groundbreaking Learning Centre

Digital Health Global

This flagship initiative is a natural extension of prior WBF forums in which the importance of determining sex and gender differences has been discussed with the entire healthcare ecosystem – policymakers, academia, patient association, drug developers, regulators and funding agencies.